TECOGEN INC. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by TECOGEN INC. (OTCQX: TGEN) on December 8, 2022. The report addresses corporate governance changes effective as of December 7, 2022, specifically regarding the Board of Directors.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on personnel appointments and does not contain financial statements or performance data.
Material Changes
The primary material change reported is the appointment of Dr. John M. Albertine as a director of the Company and a member of the Audit Committee. This appointment was made to fill a vacancy on the Board of Directors via Unanimous Written Consent of Directors dated November 28, 2022.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for future guidance, management outlook, specific risks, contingencies, or unusual items. The document is limited to the disclosure of the director appointment.
Key Facts for Investor Verification
- Dr. John M. Albertine has been appointed as a new director and Audit Committee member.
- The appointment was formalized by Unanimous Written Consent on November 28, 2022, and announced on December 7, 2022.
- The filing contains no financial performance data or forward-looking guidance.